The role of phosphodiesterase inhibitors in impotence

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.12, 1997-12, pp. : 1803-1810

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase inhibitors in clinical urology

By Ückert Stefan Kuczyk Markus A Oelke Matthias

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 323-332

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 385-387

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 11, 1997-11 ,pp. : 1355-1357

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase Inhibitors for Cognitive Enhancement

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3329-3334

Bentham Science Publishers

Access to resources Recommend Favorite

ADMET considerations for phosphodiesterase-5 inhibitors

By Rezvanfar Mohammad Amin Rahimi Hamid Reza Abdollahi Mohammad

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1231-1245

Informa Healthcare

Access to resources Recommend Favorite